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Components selected for EU Harmonized Amphetamine Profiling  
4-Methyl-5-phenylpyrimidine
4-Benzylpyrimidine
N,N -Di-(β-phenylisopropyl) amine
N,N -Di-(β-phenylisopropyl)formamide
N -(β-Phenyl-isopropyl)benzyl methyl ketimine
N -Benzoylamphetamine
1-Phenyl-2-propanol
2-Oxo-1-phenyl-(β-phenylisopropylamino)propane
N -(β-Phenylisopropyl)cathinone
Benzyl methyl ketoximine
2-Methyl-3-phenylaziridine
1,3-Diphenyl-2-propyiamine
N -Formylamphetamine
N,N -Di-(β-phenylisopropyl)methylamine
2,4-Dimethyl-3,5-diphenyl-pyridine
N -Acetylamphetamine
N -Benzylamphetamine
1-Oxo-1-phenyl-2-(β-phenylisopropylamino)propane
N ,β-Hydroxy-N,N-di-(β-phenylisopropyl)amine
2-Nitro-1-phenyl-propene
N -(β-Phenyl-isopropyl)benzaldimine
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Figure 1. A general scheme for the origin of the different components found in gas chromatograms of seized 
materials.  
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Figure 2. Possible changes in precursor supply methods. The aim of illicit suppliers of substances is to exploit 
any weakness in the multitude of legal or trade control measures to deliver the required precursors or 
product to the desired destination. [46,47]  
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Figure 3. Amphetamine impurities reported by the authors previously. [50,53,54]  
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Figure 4. Schematic showing examples of by-products formed during the acidic hydrolysis of APAAN. By-
products derived from benzaldehyde and P2P  dimerization. The amount of stilbenes (M180) found was 
greatly dependent on the choice acid with H2SO4 >> H3PO4 >> HCl.  
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Figure 5. Proposed mechanism of 6-methyl-5-phenylpyrimidin-4-amine formation during Leuckart reaction 
conditions and mass spectral data.  
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Figure 6.  
A: GC-MS of putty sample containing amphetamine in methanol and dichloromethane.  
B: HMF-amphetamine imine: (E)-(5-(((1-Phenylpropan-2-yl)imino)methyl)furan-2-yl)methanol; 
methylglyoxal-amphetamine imine: (E)-1-((1-Phenylpropan-2-yl)imino)propan-2-one; glyoxal-amphetamine 
imine: (E)-2-((1-Phenylpropan-2-yl)imino)acetaldehyde.  
C: Proposed amphetamine-HMF imine e.i. fragmentation pattern.  
 
 
294x424mm (300 x 300 DPI)  
 
 
Page 7 of 26
http://mc.manuscriptcentral.com/dta
Drug Testing and Analysis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure 7. Relationship of the compounds discussed in this perspective to synthesis routes.        
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Introduction  
  
The Republic of Ireland has a population of approximately 4.7 million citizens.[1] 
Illicit drug misuse is tackled by legislative control mechanisms and the sole national 
forensic laboratory (Forensic Science Ireland) is tasked with detailing any controlled 
drugs present in seized materials by issuing a ‘certificate of analysis’ which is utilized 
for court purposes.[2]  
  
This perspective confines itself to exploring changes observed in the analysis of 
seized amphetamine importations to Ireland and relates these observations to 
changes in illicit amphetamine production. For any particular drug, the observation 
of changing chromatographic profiles recorded during routine forensic analyses can 
be indicative that something different has occurred during the production or 
distribution processes. These changes may occur, for example, when restrictions are 
placed on traditional precursors used by illicit amphetamine producers so that 
alternatives precursors are sought after.  
 
Amphetamine is typically imported into the Republic of Ireland from mainland 
European countries and no evidence exists for any domestic large-scale illicit 
synthesis. This paper reports on the newly identified impurities detected in Irish 
amphetamine importation seizures, some of which have been published previously, 
others presented for the first tim . Reagent purity and synthesis conditions have 
been shown to affect the components observed during analysis of seizures. Post 
synthesis additions (adulteration) and storage conditions may also have a profound 
effect on the analytical profiles obtained from seized items. The finding of new 
impurities, their abundances, the use of reagents that contain or form known 
existing impurities and post synthesis additions all have the potential to adversely 
affect existing profiling methodologies, which aim to link different seizures to a 
source.   
  
The suggestion is made that the remit of forensic drug laboratories, which is 
presently centered on uniquely identifying the presence of controlled substances in 
submitted samples for law enforcement purposes, could be expanded to encompass 
other objectives. For example, the data generated during routine forensic analysis 
could be made available, in secure formats, to non-forensic researchers. This would 
allow those interested in different aspects of substance misuse, to explore and base 
their findings on the most recent seizure data available. Other researchers might be 
interested in exploring raw analytical data to generate information on trends 
observed with respect to the controlled drug reported and / or what else was 
present (which may not have been be recorded in the certificate of analysis issued 
for law enforcement purposes). Forensic drug laboratories typically store electronic 
analytical data for long periods of time, so retrospective examination of previously 
generated data is possible. Those forensic institutes that utilize profiling 
methodologies for intelligence led policing need up to date information on any new 
trends observed in illicit amphetamine production. 
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The forensic analysis of drug seizures 
 
Forensic drug laboratories analyze substances seized by law enforcement officers 
that are suspected of containing a controlled drug. From a regulatory perspective, 
forensic laboratory personnel are under pressure from law enforcement agencies to 
issue the results of laboratory tests on the contents of exhibits submitted in a timely 
manner. This is to ensure that any charges that may have to be processed through 
the legal system are initiated within a reasonable timeframe. When forensic 
laboratory personnel are dealing with drugs seizures, the main objective of their 
analyses is to identify and confirm the presence of a legally controlled substance 
present in the materials submitted. Analytical strategies and methods are devised to 
allow for typical seizures to be examined in a routine and efficient manner. These 
routine analytical methods are normally qualitative in nature, robust, capable of 
detecting a large range of compounds and dealing with large variations in drug 
concentrations. The routine analytical methods employed should identify both 
known and generally encountered controlled drugs and also indicate the presence of 
newly encountered substances.[2-4] 
 
Both liquid chromatography mass spectrometry (LC-MS) and gas chromatography 
mass spectrometry (GC-MS) methods are typically employed in the routine forensic 
analysis of controlled substances.[5-7] A distinct advantage GC-MS analysis has in 
routine analysis is that the mass spectral data generated is typically generated using 
standard ionization conditions and is generally unique to a particular compound or a 
class of compounds. Therefore, the mass spectral data generated from GC-MS 
instruments lend themselves to the use of searchable libraries, which greatly aid in 
the identification of substances. Many forensic laboratories share mass spectral 
library data on newly encountered substances via assorted international 
organizations.[8,9] There are some limiting factors in the use of GC-MS analysis for 
routine analyses, the sample components taken from the seizure must be soluble in a 
suitable solvent and also be sufficiently volatile. Thermally labile components can 
suffer from degradation, which may result in the chromatogram reflecting artificially 
induced pyrolysis products rather than the components actually present in the 
sample. In an attempt to increase volatility and enhance chromatographic 
properties, many laboratories use assorted derivatization methods.[10,11] 
 
The recent emergence of new psychoactive substances (NPS) (560 of which were 
notified to the European Monitoring Centre for Drugs and Drug Addiction since 
2008) can pose analytical challenges associated with their unique identifications.[12-
14] Assorted ring-substitutions and additions to the nitrogen and to the side-chain of 
phenethylamines and β-keto-phenethylamines have been encountered amongst 
emerging NPS.[13-17] Many forensic laboratories have to use analytical techniques not 
previously routinely utilized in their respective laboratories to uniquely identify 
compounds.   In   the   case   of   many   forensic laboratories, including our own, this 
has resulted in increased interactions with non-forensic institutions and researchers 
who have access to the required instruments. 
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Profiling – redundant or effective in a changing precursor environment? 
 
The comparison of data generated from different seizures forms a central part in 
profiling activities. The central objective of any profiling exercise is to examine data 
and to propose linkages of different seizures to a common source.[18-22] The data 
compared can be chemical, such as residual solvents or impurities, or be physical, 
such as size, shape, logo impressions or markings. Profiling methodologies require 
that data be obtained in a consistent manner and for data on different seizures to be 
collated in computerized data analysis systems. Analytical profiling methods 
normally focus in on the minor components (impurities) rather than major 
components in seizures. An impurity may originate from many sources including; a 
synthesis side reaction, a diluent added later to bulk up the end product, an 
adulterant added to mimic some physical property of the desired compound or 
substances added to allow the product to be tableted or flow freely as a powder. 
 
Illicit drug productions are typically done in batch type processes and inter and intra 
batch variations may occur. Inter-batch variations may occur due to any differences 
or changes made in the production process from run to run. Intra- batch variation 
may occur for a number of reasons including inhomogeneity of reagents or the 
presence of hot spots (temperature spikes) in synthesis equipment that may 
produce random side reaction products. For a profiling method to be successful, 
intra-batch variations should ideally be comparatively smaller than inter-batch 
variations for the particular components or impurities selected for 
comparison.[20,23,24] Generally, the degree of relationship between samples from 
seizures is measured by the assigning a score, utilizing comparison metrics like 
scatter plot data, pearson correlation, modified square cosine and euclidean 
distance.[20,22,25-28] 
Profiling is a very time consuming exercise and, in general, once a large amount of 
population data is collected, it may become difficult to change data collection 
parameters. The analytical run times employed for GC-MS profiling tend to be much 
longer that those employed in routine analysis. This allows for the resolution of any 
co-eluting components that may be present during shorter routine analysis. 
Whatever the choice of analytical profiling methodology employed, the components 
selected for comparison and how they are to be measured have to be decided from 
the outset and applied consistently so that population data can be collected.[20,29-31] 
 
When changes occur in the synthesis of the precursors required for conventional 
illicit production methods, this can add an additional layer of complexity to the 
interpretation of the significance of specific by-products present in any final product. 
Information on the by-products arising from any new precursor production methods 
encountered needs to be borne in mind as to its possible effects on any by-products 
measured as part of an established harmonized profiling methodologies.  
  
Discriminatory aspects of impurities 
 
With profiling, the components selected for quantification and subsequent 
comparisons should be discriminating to some extent. An example of 21 substances  
chosen  for  comparison  is  included  in  Table  1  for  a  European harmonized 
method designed for the profiling of amphetamine. These 21 by- products were 
selected as typical, for at least one of the three most common amphetamine 
synthesis approaches employed in Europe. Two of these routes employ phenyl- 2-
propanone (P2P), namely the Leuckart route and the reductive amination route and 
finally, the nitrostyrene  (oxime) route.[18,32] 
Page 12 of 26
http://mc.manuscriptcentral.com/dta
Drug Testing and Analysis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Table 1. Substances associated with specific synthesis routes and chosen for 
comparison in a European amphetamine profiling study. [18,32]   
 
What is actually seen and recorded in the chromatogram of a seized sample is 
dependent on a number of factors that include: the synthesis methods employed, 
technical sophistication of the apparatus, size of production, sample preparation 
and the response of the analytical instrument to particular components present in 
the sample. A general scheme for the origin of the different components found in the 
chromatograms of seized material is outlined in Figure 1. Gaining an understanding 
of all aspects of production and at what stage in the production or post-production 
processes particular substances might arise is critical to making informed decisions 
about the stability and the discriminating nature of particular components found in 
the seized material. As time passes, new reagents or new illicit production synthesis 
routes may be employed that alter the discriminatory power of particular 
components or a highly discriminating new by-product may be identified. Sharing 
findings about unusual or novel impurities found during routine examination of 
seized items with others forensic laboratories (especially those using profiling 
methods) and with the wider scientific community is important and should be 
valued as part of a forensic laboratories remit. 
 
Figure 1. A general scheme for the origin of the different components found in gas 
chromatograms of seized material.   
 
Amphetamine production in Europe 
 
Amphetamine has a long history of use and misuse and it has been extensively 
studied.[33] It was first synthesized in Germany in 1887[34,35] and is a synthetic 
derivative of phenethylamine (2-phenylethan-1-amine) and is chiral in nature.[36] 
Derivatives of amphetamine comprise a large number of substances, with varying 
substituents attached at the phenyl ring, α-carbon or nitrogen.[12,37] The synthesis 
routes to both amphetamine and methamphetamine overlap significantly. Some 
synthesis impurities have been reported to be ‘route specific’ to a particular 
synthesis route and as such may be selected as targeted components in profiling 
methodologies as highly discriminating substances (see Table 1)[20,23,32, 38-40]. Some 
researchers have demonstrated that when the synthesis procedures were 
performed in a controlled environment, e.g. using the same reagents, experimental 
vessels, production method and operator, some components were observed in 
varying amounts following multiple repeats.[41] Illicit amphetamine manufacture is 
generally performed outside controlled environments by untrained chemists, thus, 
potentially leading to considerable variation in synthesis conditions employed for 
particular production batches. 
In Europe, the use of P2P as a starting material for the Leuckart reaction remains the 
most dominant route to amphetamine production. Europol reported that in 2013-
2014, of the 62 amphetamine production sites of known synthesis routes, 48 used 
P2P as the precursor and at 42 of these 48 sites, the Leuckart synthesis route was 
used.[38,42] Large amphetamine production facilities have been found for 
amphetamine in the Netherlands, Belgium, Poland, The Baltic States, Bulgaria, 
Germany and Turkey. In 2014, the total reported seizure data for amphetamine in 
Europe was 7.1 tons.[42] 
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Ephedrine can easily be converted to methamphetamine. Ephedrine is generally 
employed in larger scale illicit productions, especially when nearby legitimate 
manufacturing and some diversion of ephedrine stock occurs. More typically, 
ephedrine (obtained from over the counter medications) may be found in smaller 
scale domestic type productions. Methamphetamine destined for the European 
market is predominately synthesized in the Czech Republic, although production 
facilities were also discovered in Germany, Austria and Bulgaria during 2014.[12,42] 
Research into amphetamine synthesis in recent years has moved from classical 
methods to developing methods that target specific chiral versions of ATS. It remains 
true, however, that most illicit ATS production facilities detected still employ classic 
synthesis routes.[35] 
 
The legitimate sale and distribution of both P2P and ephedrine are internationally 
monitored and subject to control measures. The availability of starting materials to 
illicit producers supplied by criminal organizations also appears to be tightly 
controlled. It has been reported that, ordinarily, no excess starting materials were 
found at numerous raids on European illicit production sites, therefore, it could be 
surmised that exact volumes of P2P are provided ‘on demand’ for each production 
batch.[43]  In addition, clandestine laboratory investigators have found precursor 
production is taking place at production sites separate from those where the desired 
drugs are being prepared. There is further evidence to suggest that the distinct 
production stages in the illicit manufacture of drugs are spreading to different 
locations, possibly in attempts to evade detection. For example, in 2015 several 
European countries reported that amphetamine base oil from the Netherlands was 
converted to amphetamine sulfate on their territories.[42,43] The increase in the 
number of locations where production is in progress increases the number of sites 
where chemical waste is generated. The amount of waste generated at a Leuckart 
amphetamine production facility has been estimated to range from 18 to 24 
kilograms of chemicals for every kilogram of amphetamine produced.[36] The 
disposal of such an amount of waste is an obvious environmental concern. The 
Netherlands reported that 157 illicit chemical dumping sites were found in 2014 
with an average of 800 kilograms of waste per site.[42,44] Whatever the size of an 
illicit production facility, the dumping of waste from these sites poses a major health 
risk to the general public and first responders at such dump locations. From a 
forensic evidence viewpoint, any assistance in linking components found in waste to 
seizures or production sites would be beneficial. 
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Alternatives options when restrictions apply to traditional starting materials 
for amphetamine production 
 
When restrictions are placed on the sale or international trade of existing 
precursors, alternative sources of supply are needed for illicit producers to 
circumvent these restrictions: 
 
A. Diversion of starting materials from manufacturers who have regulated 
access to and large stocks of the required reagents; 
B. Falsely declared or concealed contents of imported reagents with the hope 
that the shipment gets through international custom controls; 
C. Bulked purchases and storage of desired reagents prior to them becoming 
internationally monitored; 
D. Identification of an alternative route to obtaining the desired starting 
materials using as yet freely available, unmonitored reagents; 
E. International suppliers may be asked to supply a compound using 
nomenclature that does not make the supplier aware that it is supplying a substance 
that is in fact controlled in the destination country; 
F. The required chemical supplies and equipment might be obtained from 
specialized criminal organizations. 
 
International criminal organizations change their supply routes to all levels of the 
illicit market over time. In recent years, they became distributors rather than 
manufacturers of ‘product’, supplying on-line and head-shop retailers, as well as 
their traditional illicit drug market vendors.[14,42] Obtaining product and remaining 
‘legal’ (and thus beyond control mechanisms) may provide information about what 
appears to be the possible start of a new trend in the supply of precursors for illicit 
production facilities. Rather than providing the final desired product, which may or 
may not be nationally or internationally controlled, a compound may be supplied 
that structurally falls just short of the desired substance but which can be easily 
manipulated to the desired substance. Alternatively, some moiety may be added to 
the desired synthesized substance that can subsequently be easily removed. For 
example, some on-line drug forums are discussing claims made by an Israeli chemist 
that he can supply a ‘meth-expresso’ type apparatus, which is stated to allow a 
purchaser to convert a currently legal substance into a controlled substance in the 
privacy of their own home.[45] Alternatively, derivative versions of controlled 
substances or pro-drugs might be supplied. This potential change in precursor 
supply scenario is represented in Figure 2, where the desired product is represented 
as a stop line at a junction, which is deliberately over or under shot, making the 
supplied product have a status of not monitored or controlled. There are seizures 
reported where derivativized drugs rather than the drugs themselves have been 
detected.[46,47] The illicit precursor suppliers exploit the fact that in many countries 
(including Ireland), no legal sanctions apply to substances that are not specifically 
listed either internationally or in their respective national legislation as 
precursors.[48] 
 
Figure 2. Possible changes in precursor supply methods. The aim of illicit suppliers of 
substances is to exploit any weaknesses in the multitude of legal or trade control 
measures to deliver the required precursors or product to the desired destination. [46,47]
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Analysis of Irish amphetamine importation seizures 
 
Ireland is not a major producer of illicit substances including ATS. Law enforcement 
seizure of substances suspected of containing controlled materials, tend to be street 
level quantities, local dealer distribution quantities or importations from European 
criminal organizations with links to Irish criminal gangs. Importations may be 
destined for the domestic market or in transit on route to another country. A few 
small-scale ‘kitchen type’ production facilities in domestic settings reducing pseudo-
ephedrine, obtained from over the counter medications to methamphetamine have 
been found and dismantled in recent years. There is evidence of some coordinated 
buying of ephedrine-based medications from pharmacies and increased regulation is 
currently under consideration with respect to the sale of these products.[49] 
 
In 2013, an Irish customs amphetamine importation seizure was analysed, 1-benzyl-
3-methylnaphthalene and 1,3-dimethyl-2-phenyl-naphthalene were found as 
impurities in the seizure. This pair of isomeric naphthalenes was previously 
reported as specific to amphetamine synthesized from ephedrine, however, it also 
contained P2P Leuckart route specific components [50] (Figure 3). Personal 
communications from Dutch colleagues indicated that α-phenylacetoacetonitrile 
(APAAN) was found at some illicit production sites in 2012/2013 and it was 
suggested that APAAN acidic hydrolysis was a newly employed route to P2P 
production.[51] In 2013, no information was available in the literature that 
specifically examined the impuriti s that might be found in P2P derived from the 
acid hydrolysis of APAAN. In-house experiments were conducted involving the 
sulfuric acidic hydrolysis of APAAN to yield P2P. This in-house P2P was 
subsequently used to synthesize amphetamine, via the Leuckart method. On analysis 
of the in-house generated amphetamine, similar GC-MS chromatographic profiles to 
those acquired for the 2013 customs importation seizure were obtained. This ‘new’ 
route to P2P contained impurities previously associated with an ephedrine based 
amphetamine synthesis route. 
 
Figure 3. Amphetamine impurities reported by the authors previously. [50,53,54] 
 
In Europe, the reported seizures of P2P had rapidly declined in the years 2009 to 
2013, although there was no corresponding decrease in the supply of amphetamine 
to the wider European market.[52] Shipments of APAAN to Europe were increasing 
with little known legitimate commercial use for this pre- precursor. In 2013, 36 tons 
of APAAN were seized in the Netherlands and 5.4 tons were seized in Belgium.[42] 
Separate dedicated APAAN to P2P production facilities were discovered in Poland 
and subsequently linked to Dutch illicit drug producers. APAAN was scheduled in the 
European Union (EU) as a precursor in December 2013 and became an 
internationally monitored chemical after a UNODC Commission on Narcotic drugs 
decision 57/1 in March 2014.[43] The ingenuity and chemical know how of those 
behind supplying illicit producers was demonstrated with the finding of 3-oxo-2-
phenylbutanamide also known as α-phenylacetoacetamide (APAA), a substance that 
can also easily be converted to P2P, at a Dutch amphetamine production site in 
2013.[12] This might indicate that illicit producers had already investigated ways to 
circumvent the APAAN control measures prior to its introduction.
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In 2015, over 600 kg of APAA was seized in Poland and Germany.[42] Worldwide 
seizures of P2P derivatives, phenylacetic acid and benzaldehyde have increased in 
recent years, indicating a shift to P2P as the main precursor used in both North and 
Central America, as well as in Europe, in the production of both amphetamine and 
methamphetamine.[12,13,15] 
 
In some in-house experiments, which involved the sulfuric acid hydrolysis of APAAN, 
a large amount of a white substance precipitated from solution, which was isolated 
and identified as 4,6-dimethyl-3,5-diphenylpyridin-2-one[53] (Figure 3). The 
provision of information about new impurities arising from new methods of 
production is important for clandestine laboratory investigators. These investigators 
often examine sites where active production has ceased. The amount of impurities 
present in waste materials may be greater than quantities observed in the final 
production product. Consequently, the ability to link impurities from samples taken 
at various stages in production to a possible synthesis route is beneficial. The 
detection of 4,6-dimethyl-3,5-diphenylpyridin-2-one in amphetamine seizures 
suggested that the P2P used in the amphetamine synthesis might have derived from 
APAAN. 
 
APAAN hydrolysis experiments 
 
APAAN, when subjected to acidic medium forms P2P and benzaldehyde along with 
other by-products. Dimerization and subsequent condensation reactions between 
these by-products and APAAN account for many of the impurities detected in the 
final products of the acidic hydrolysis experiments. Experiments on the acidic 
hydrolysis of APAAN continued in the authors’ laboratories with variations of some 
of the conditions that might occur at an illicit production site, such as varying 
reaction time, acidic strength and acid employed. It was hoped that the experiments 
might identify potential impurities that would be indicative of the production 
process and specific acid used for hydrolysis. Hydrochloric acid, sulfuric acid and 
phosphoric acid have been reported as used in discovered APAAN conversion 
facilities. 
 
The major and consistently observed feature of the acid hydrolysis of APAAN was 
that both cis and trans stilbenes (M180) were found with all three acids used in the 
hydrolysis experiments but in vastly different quantities. Stilbene abundance was 
greatest with sulfuric acid as the hydrolyzing agent, much less was detected with 
phosphoric acid and only minor trace quantities with hydrochloric acid. Stilbene 
formation was reversible and essentially occurred from the dimerization of P2P and 
benzaldehyde (M222) and subsequent condensations. When investigating the ratio 
of cis to trans stilbene, it was noted that under strong acidic conditions cis-stilbene 
converted to trans-stilbene but not vice versa. In hydrochloric acid experiments on 
the by-product M222, 1-methylene-2-phenyl-1H-indene (M204) was predominately 
formed in preference to stilbene formation (Figure 4). 
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Figure 4. Schematic showing examples of by-products formed during the acidic 
hydrolysis of APAAN. By-products derived from benzaldehyde and P2P  dimerization. 
The amount of stilbenes (M180) found was greatly dependent on the choice acid with 
H2SO4 >> H3PO4 >> HCl. 
 
The isomers 1-benzyl-3-methylnaphthalene and 1,3-dimethyl-2-phenyl- 
naphthalene were found in all APAAN acid hydrolysis experiments to varying 
degrees. Under the conditions studied, acid-specific by- products could not be 
detected. One noteworthy impurity found in the APAAN hydrolysis experiments was 
3-oxo-2-phenylbutanamide (APAA), a substance found at some clandestine 
amphetamine production sites, which as previously mentioned in this paper, can 
also be used to synthesize P2P under similar conditions used for APAAN hydrolysis. 
The knowledge that at least one APAAN hydrolysis impurity was itself now used as a 
starting reagent in the manufacture of P2P revealed the increasing complexity in 
trying to identify discriminating components linkable to a particular hydrolyzing 
acid. Recognizing that investigators would be looking at specific impurities present 
in any final amphetamine product, and that the experiments to date showed great 
variation in what was actually observed, further hydrolysis experiments were not 
continued. 
 
Reagent purity, post synthesis additions or distillations and analysis 
conditions may all affect the impurities observed 
 
It is useful to examine the purity of reagents used when conducting synthesis 
experiments as some impurities present may remain detectable in the final 
synthesis product or contribute to the formation of other impurities. For example, 
APAAN was observed to contain the impurity 2,3-diacetyl-2,3-
diphenylsuccinonitrile that, in the heat of a GC injection port, converted  to  2-
methyl-1-phenyl-1H-indene-1,3-dicarbonitrile (Figure  3).[54] The detection of this 
indene pyrolysis product suggested that it might be an analytical marker for the 
involvement of APAAN in the amphetamine production process, at least when 
employing GC-based analysis. 
 
In a 2016, a customs importation seizure was submitted for analysis. This seizure 
consisted of a bi-layered liquid with a lower colorless layer and top layer of what 
appeared to be a red oily liquid. Both layers were examined by GC-MS and both 
were found to contain amphetamine. The red liquid showed a concentration of 
amphetamine free base at 40%(w/w), whereas the colorless liquid revealed an 
amphetamine concentration of 2%(w/w). The importation of this liquid was 
speculated to represent an example of the diversification of the final amphetamine 
production stage to different locations. Because the importation consisted only of 5 
liters of liquid, it may have been a trial or test importation to check custom controls 
or to check the customer’s view of the product in that physical form.  The GC-MS 
chromatogram of the red oil showed a profile typical for APAAN to P2P Leuckart 
generated amphetamine as observed in our laboratory with the exception of one 
relatively large peak.  This peak had a mass spectrum base peak at m/z 185 and a 
second peak about 80% of the base peak at m/z 184. 
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It was speculated that something concerning the reagents and or production 
conditions had changed to a significant extent so that the abundance of this impurity 
had significantly increased. Experiments were conducted that examined the range of 
compounds known to be present at APAAN to amphetamine production facilities. 
One set of experiments were designed to investigate the reaction products found 
when APAAN was subjected to Leuckart reaction conditions, which included the 
extension of reaction times (APAAN, ammonium formate and formic acid at 130° 
Celsius for 14 h). The resulting product was first acid extracted and subsequently 
base extracted. A peak at the same retention time and with the same mass spectral 
fragmentation pattern was observed as the major component in the base extract and 
suspected to represent 6-methyl-5-phenylpryimidin-4-amine. This compound was 
subsequently synthesized and   NMR   analysis   conducted which confirmed the 
substitution arrangement of the pyrimidine.  The conclusion drawn was that the 
presence of APAAN in any batch production of P2P, followed by Leuckart reaction 
conditions, would result in the detection of 6-methyl-5-phenylpryimidin-4-amine in 
the amphetamine product. It is suggested that 6-methyl-5-phenylpryimidin-4-amine 
is more likely to be observed, when the Leuckart reaction times and/or 
temperatures are extended beyond what is typically employed during this synthesis. 
A proposed mechanism of formation of 6-methyl-5-phenylpryimidin-4-amine and 
the corresponding mass spectral data are shown in Figure 5. It is suggested that 
formaldehyde reacts with the nitrile (addition reaction) and with the carbonyl 
carbon to form a Schiff base). This might be followed by loss of CO and ring closure 
and subsequent loss of H2O from the tautomer to yield 6-methyl-5-phenylpryimidin-
4-amine. The presence of pyridines and pryimidines has long been associated with 
the Leuckart synthesis of P2P.[40,55,56]. To the authors’ knowledge, the formation and 
detection of 6-methyl-5-phenylpryimidin-4-amine in association with amphetamine 
manufacturing has not yet been reported. A sample from the 2013 amphetamine 
paste importation was re-analyzed, which confirmed the detection of this impurity, 
thus, adding to the suggestion that the P2P used in the seized material from 2013 
was prepared from APAAN. 
 
Figure 5. Proposed mechanism of 6-methyl-5-phenylpryimidin-4-amine formation 
during Leuckart reaction conditions and mass spectral data. 
 
 
Post synthesis additions 
 
The post synthesis addition of substances can also significantly affect the impurity 
profiles observed during analysis. Some of these effects were evident during routine 
GC-MS analysis of seized brown putty-like materials submitted as street deals 
suspected to contain and sold as amphetamine in early 2016. When dissolving some 
of the putty-like material in methanol in preparation for routine GC-MS analysis, a 
significant amount of white powder (greater than 80%, w/w) precipitated from 
solution and analysis by infrared (IR) and by thin layer chromatography (TLC) 
showed   this   powder   to   be   a   mixture   of     sugars,
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predominantly consisting of lactose. The soluble putty material underwent routine 
GC-MS analysis, and initially, no amphetamine was detected in the resulting 
chromatogram. However, many of the components commonly observed in a APAAN 
to amphetamine conversion were detected, such as, P2P, pyrimidines, N-
formylamphetamine, N-acetylamphetamine and a pair of naphthalenes. Surprisingly, 
when the same sample analyzed by TLC, a strong amphetamine spot was observed, 
which suggested that complete degradation of amphetamine must have occurred 
during GC-MS analysis. 
 
One of the peaks present in the GC-MS profile of the methanolic extract obtained 
from the putty–like material was attributed to hydroxymethylfurfural (HMF). 
Assorted sugars including lactose are commonly found in seizures of powders 
suspected of containing amphetamine and HMF can be obtained from the 
dehydration of certain sugars. Fermentation of sugars can produce 3- 
hydroxybutanone (acetoin) and butanedione (diacetyl). Methylglyoxal and glyoxal 
are other known dicarbonyls produced when sugars are subjected to  heat and 
humidity.[56-59] As a consequence, these sugar by-products can impact on the quality 
of amphetamine during storage or during chemical analysis, for example, by forming 
assorted imines (Schiff bases). When an amphetamine standard in methanol was 
injected along with glyoxal, methylglyoxal or HMF into the GC-MS, an almost 
complete disappearance of amphetamine was observed, and imines were detected 
as analyses by-products. The choice of GC-MS solvent influenced the formation of the 
imines. When mixtures of th  putty amphetamine sample with glyoxal, 
methylglyoxal or HMF were analyzed by GC-MS using dichloromethane, ethylacetate 
or toluene as the solvent, amphetamine could be observed in the chromatograms 
(Figure 6A). Consequently, these results challenged the robustness of the routine 
qualitative GC-MS method for the detection of amphetamine in the presence of 
sugars. The presence of HMF and amphetamine in the heat of the GC injection port 
led to the formation of an amphetamine-HMF imine, suggested to be ((5-(((1-
phenylpropan-2- yl)imino)methyl)furan-2-yl)methanol and similar imines were 
formed with methylglyoxal and glyoxal (Figure 6B). An added complication for the 
determination of the compounds formed when sugars are also present is that imine 
formation is pH dependent and that hydrolysis can reverse this process. A electron 
ionization mass spectra fragmentation pathway for the HMF-amphetamine imine  
(m/z  243, 152(base  peak), 136, 123, 91)  is proposed.(Figure 6 C). 
 
HMF itself can degrade and form formic acid. When an amphetamine standard was 
analyzed by our routine GC-MS qualitative analysis method in the presence of HMF 
and methanol, N-formyl-amphetamine was detected along with the amphetamine-
HMF imine. N-Formyl-amphetamine has previously been thought of as a specific 
marker for the Leuckart synthesis route and the addition of sugars post synthesis 
has been shown to have a considerable influence on the components detected in an 
amphetamine product with consequent implications for synthesis route 
determinations and profiling methodologies. 
 
Figure 6.  
A: GC-MS of putty sample containing amphetamine in methanol and dichloromethane.  
B: HMF-amphetamine imine: (E)-(5-(((1-Phenylpropan-2-yl)imino)methyl)furan-2-
yl)methanol; methylglyoxal-amphetamine imine: (E)-1-((1-Phenylpropan-2-
yl)imino)propan-2-one; glyoxal-amphetamine imine: (E)-2-((1-Phenylpropan-2-
yl)imino)acetaldehyde.  
C: Proposed amphetamine-HMF imine e.i. fragmentation pattern.
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The presence of sugars in illicit preparations could also account for the browning 
sometimes observed over time in some amphetamine powder cases due to Maillard-
type reactions.[60] The extent of these Maillard reactions depends on variations in 
pH, humidity and temperature, which are factors that may change significantly 
during storage and transport of the illicit products before reaching the drug users. 
This phenomenon is reminiscent of the browning that can be observed in tablets 
containing assorted amphetamine-type stimulants that are formulated with sugars 
and cellulose, both of which can lead to HMF formation and may be responsible for 
flecks of brown appearing or browning of these tablets. The conclusion drawn from 
these observations was that alcohols are poor GC-MS solvents to use when 
investigating seizures suspected of containing ATS that may also contain sugars. 
Amphetamine is a primary amine and other primary amines such as procaine and 
benzocaine may be present as adulterants along with sugars in illicit seizures of 
street level amphetamines. In these situations, the use of alcohols as a GC-MS solvent 
might therefore als  have implications on the analysis of these compounds.[61]  
 
Conclusion 
 
For forensic laboratories involved in seeking to enforce controlled drug legislation, 
analytical challenges will be continuously present as long as new and untested 
substances continue to be made available. It is desirable that timely information is 
made available to forensic drug analysts on how substances are synthesized, new 
trends in illicit manufacture and what other substances may be present in seized 
materials. Links to academic institutions or industry should be encouraged so as to 
foster research as Government funded enforcement laboratories have limited time 
to research the materials presented to them. If benefits are to accrue from increased 
co-operation at a national or international level, then, a value needs to be placed on 
this type of information exchange and time allocated to these activities within 
national forensic institutions. 
 
The analytical methods and instruments potentially available to law enforcement 
laboratories are continuously improving, but it is clear that in some cases highly 
specialized instruments will be required to uniquely identify what is actually present 
in the illicit products seized. Time spent researching some Irish amphetamine 
importation seizures has led to an increased awareness of the complexity and range 
of impurities that may be present. New compounds not previously associated with 
amphetamine manufacture have been identified. Post synthesis additions have been 
shown to challenge the ability of some traditional analytical approaches to detect 
certain substances and these factors have implications for impurity profiling 
methodologies. Adulteration of products, either intentionally post synthesis or 
unknowingly as part of the manufacturing process, might also add an unknown 
health risk for the consumer. Figure 7 attempts to graphically show the complexity 
and relationships between some of the compounds discussed in this perspective. 
The reality remains that illicit amphetamine production processes will continue to 
change and be modified as long as it remains profitable for producers and demand 
for the product exists.  The suitability of the instrumentation and analytical methods 
currently employed forensic drug testing laboratories for use in law enforcement 
should be periodically assessed to determine their fitness for purpose. Those 
laboratories engaged in forensic analysis of misused substances should consider 
how their analytical data on currently abused substances might be shared with other 
non-forensic researchers. 
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Figure 7. Relationship of the compounds discussed in this perspective to synthesis 
routes.        
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